AIMP1 and myocardial infarction: In myocardial infarction mice treated with EMAP II antibody, researchers found upregulated angiogenesis-related biomarkers and increased endothelial cell, suggesting that EMAP II blockade improved cardiac function by inducing angiogenesis50.